Twist BioscienceTWST
About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Employees: 923
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
196% more call options, than puts
Call options by funds: $5.99M | Put options by funds: $2.02M
100% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]
19% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 27
9% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 82
3% more capital invested
Capital invested by funds: $2.98B [Q3] → $3.08B (+$104M) [Q4]
0% more funds holding
Funds holding: 243 [Q3] → 244 (+1) [Q4]
1.01% less ownership
Funds ownership: 112.47% [Q3] → 111.45% (-1.01%) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Goldman Sachs Matthew Sykes 43% 1-year accuracy 15 / 35 met price target | 63%upside $48 | Buy Maintained | 6 May 2025 |
Guggenheim Subbu Nambi 35% 1-year accuracy 8 / 23 met price target | 69%upside $50 | Buy Reiterated | 6 May 2025 |
Baird Catherine Ramsey 29% 1-year accuracy 5 / 17 met price target | 49%upside $44 | Outperform Maintained | 6 May 2025 |
JP Morgan Rachel Vatnsdal 50% 1-year accuracy 7 / 14 met price target | 12%upside $33 | Underweight Maintained | 6 May 2025 |
Barclays Luke Sergott 33% 1-year accuracy 21 / 63 met price target | 52%upside $45 | Overweight Maintained | 10 Apr 2025 |
Financial journalist opinion
Based on 9 articles about TWST published over the past 30 days









